Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 2013. The report details a specific share repurchase transaction executed on July 23, 2013, pursuant to shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 1,200,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,693.50 pence per share; lowest price paid was 1,674.50 pence per share.
- Treasury Holdings (Settled): 502,849,512 shares, representing 9.29% of total issued share capital.
- Treasury Holdings (Including Unsettled): 505,049,512 shares, representing 10.29% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,908,897,658 shares.
Material Changes
The primary material change is the reduction of outstanding shares through the purchase of 1,200,000 shares. Consequently, the percentage of shares held in Treasury increased to 9.29% of issued capital (or 10.29% of voting rights including unsettled trades). The filing does not provide comparative financial data to assess changes in operational performance versus prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation to purchase securities and confirms conformity with the Financial Conduct Authority's Disclosure and Transparency Rules. No specific risks or contingencies are detailed in this document.
Investor Verification Checklist
- Verify the total cost of the 1,200,000 share repurchase using the provided price range.
- Confirm the impact of the 10.29% treasury holding on total voting rights calculations.
- Check subsequent filings for the settlement status of the 2,200,000 shares included in the "purchased but not yet settled" figure.
- Review the Annual General Meeting minutes from May 1, 2013, to understand the full scope of the share buyback authority.